Tauns Laboratories (TYO:197A) has withdrawn its application to shift to the Tokyo Stock Exchange's Prime Market, citing delays in the review process and the need to revise submitted materials, according to a Monday filing on the Tokyo Stock Exchange.
The company had submitted the application using the fiscal year ended June 2024 as its reference period, but now expects the Tokyo bourse will not approve it before its upcoming shareholder meeting in September.
Tauns said it still aims to pursue a move to the Prime Market and will reassess the timing.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。